Cell Growth & Differentiation, Vol 7, Issue 10 1291-1304, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events

A Malliri, WA Yeudall, M Nikolic, DH Crouch, EK Parkinson and B Ozanne
CRC Beatson Laboratories, Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom.

Transforming growth factor beta 1 (TGF-beta 1) is a potent inhibitor of keratinocyte proliferation and a potential tumor suppressor of squamous cell carcinomas (SCCs). TGF-beta 1 exerts its antiproliferative effects by inhibiting key transitions required for progression from G1 to the S phase of the cell cycle, exemplified by a rapid reduction of c-MYC and inhibition of the G1 cyclin/cyclin-dependent kinases by induction of their inhibitors p21waf1, p27kip1, and p15INK4B. A significant majority of a new series of human SCC cell lines were found to be as sensitive as primary human epidermal keratinocytes to TGF-beta 1 growth inhibition. Only a minority of cell lines derived from late-stage tumors were resistant. An early and rapid increase in p21waf1 and reduction in c-MYC protein levels were important concomitants for TGF-beta 1 growth inhibition; these changes occurred exclusively in each of the sensitive cell lines. Expression of p15INK4B was found to be neither necessary nor sufficient for TGF-beta 1 growth arrest in the sensitive and resistant cell lines, respectively. TGF-beta 1 induced alterations in other cell cycle regulatory molecules, cyclin-dependent kinase 4, cyclin D1, pRB, and p27Kip1, occurred late and were dispensable in some of the sensitive cell lines. Expression of exogenous mycER fusion protein in one of the sensitive cell lines did not render the cells resistant to TGF-beta 1-induced growth arrest nor prevent p21waf1 induction or down-regulation of both c-MYC and mycER proteins. However, in TGF-beta 1-resistant subclones of sensitive mycER-expressing cells, p21waf1 was not induced, whereas both c-MYC and mycER protein levels decreased following TGF-beta 1 treatment. We conclude that TGF-beta 1 activates multiple cell cycle inhibitory pathways dependent upon p21waf1 induction and c-MYC degradation and that it does not function as a tumor suppressor in the majority of SCCs.

This article has been cited by other articles:

				T. Makino, K. Ishikawa, I. Igarashi, T. Yamoto, S. Manabe, and H. Nakayama Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers Toxicol Pathol, April 1, 2008; 36(3): 420 - 427. [Abstract] [Full Text] [PDF]

				E. Perez-Gomez, M. Villa-Morales, J. Santos, J. Fernandez-Piqueras, C. Gamallo, J. Dotor, C. Bernabeu, and M. Quintanilla A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis Cancer Res., November 1, 2007; 67(21): 10268 - 10277. [Abstract] [Full Text] [PDF]

				K. D. Hunter, J. K. Thurlow, J. Fleming, P. J.H. Drake, J. K. Vass, G. Kalna, D. J. Higham, P. Herzyk, D. G. MacDonald, E. K. Parkinson, et al. Divergent routes to oral cancer. Cancer Res., August 1, 2006; 66(15): 7405 - 7413. [Abstract] [Full Text] [PDF]

				S.-H. Kim, J. Rowe, H. Fujii, R. Jones, B. Schmierer, B.-W. Kong, K. Kuchler, D. Foster, D. Ish-Horowicz, and G. Peters Upregulation of chicken p15INK4b at senescence and in the developing brain J. Cell Sci., June 15, 2006; 119(12): 2435 - 2443. [Abstract] [Full Text] [PDF]

				X.-Z. Chi, J.-O. Yang, K.-Y. Lee, K. Ito, C. Sakakura, Q.-L. Li, H.-R. Kim, E.-J. Cha, Y.-H. Lee, A. Kaneda, et al. RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor {beta}-Activated SMAD Mol. Cell. Biol., September 15, 2005; 25(18): 8097 - 8107. [Abstract] [Full Text] [PDF]

				J. S. Edmiston, W. A. Yeudall, T. D. Chung, and D. A. Lebman Inability of Transforming Growth Factor-{beta} to Cause SnoN Degradation Leads to Resistance to Transforming Growth Factor-{beta}-Induced Growth Arrest in Esophageal Cancer Cells Cancer Res., June 1, 2005; 65(11): 4782 - 4788. [Abstract] [Full Text] [PDF]

				S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]

				A. Khanna Concerted effect of transforming growth factor-{beta}, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1133 - H1140. [Abstract] [Full Text] [PDF]

				P. M. Siegel, W. Shu, and J. Massague Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression J. Biol. Chem., September 12, 2003; 278(37): 35444 - 35450. [Abstract] [Full Text] [PDF]

				K. E. Gordon, H. Ireland, M. Roberts, K. Steeghs, J. A. McCaul, D. G. MacDonald, and E. K. Parkinson High Levels of Telomere Dysfunction Bestow a Selective Disadvantage During the Progression of Human Oral Squamous Cell Carcinoma Cancer Res., January 15, 2003; 63(2): 458 - 467. [Abstract] [Full Text] [PDF]

				B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638. [Abstract] [Full Text] [PDF]

				K. Yagi, M. Furuhashi, H. Aoki, D. Goto, H. Kuwano, K. Sugamura, K. Miyazono, and M. Kato c-myc Is a Downstream Target of the Smad Pathway J. Biol. Chem., January 4, 2002; 277(1): 854 - 861. [Abstract] [Full Text]

				C. A. Bradham, E. Hatano, and D. A. Brenner Dominant-negative TAK1 induces c-Myc and G0 exit in liver Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1279 - G1289. [Abstract] [Full Text] [PDF]

				M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta , a type beta transforming growth factor (TGF-beta ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway PNAS, January 4, 2000; 97(1): 109 - 114. [Abstract] [Full Text] [PDF]

				B. J. Warner, S. W. Blain, J. Seoane, and J. Massague Myc Downregulation by Transforming Growth Factor beta Required for Activation of the p15Ink4b G1 Arrest Pathway Mol. Cell. Biol., September 1, 1999; 19(9): 5913 - 5922. [Abstract] [Full Text] [PDF]

				A. Iavarone and J. Massague E2F and Histone Deacetylase Mediate Transforming Growth Factor beta  Repression of cdc25A during Keratinocyte Cell Cycle Arrest Mol. Cell. Biol., January 1, 1999; 19(1): 916 - 922. [Abstract] [Full Text] [PDF]

				A. Malliri, M. Symons, R. F. Hennigan, A. F.L. Hurlstone, R. F. Lamb, T. Wheeler, and B. W. Ozanne The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells J. Cell Biol., November 16, 1998; 143(4): 1087 - 1099. [Abstract] [Full Text] [PDF]

				S. W. Blain and J. Massague Different Sensitivity of the Transforming Growth Factor-beta Cell Cycle Arrest Pathway to c-Myc and MDM-2 J. Biol. Chem., October 6, 2000; 275(41): 32066 - 32070. [Abstract] [Full Text] [PDF]

				G. F. Claassen and S. R. Hann A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest PNAS, August 15, 2000; 97(17): 9498 - 9503. [Abstract] [Full Text] [PDF]